Contract 36F79722D0202
Cti Biopharma Corp. · Department Of Veterans Affairs · December 19, 2024
Cti Biopharma Corp. was awarded a federal contract by Department Of Veterans Affairs on December 19, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 1, 2025. If all options are exercised, the contract could reach $3.00 million.
Contract details
- PIID
- 36F79722D0202
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- December 19, 2024
- Latest action
- October 1, 2025
Description
CONTRACT CANCELLATION
Modification timeline
-
October 1, 2025Mod P00009 · Supplemental Agreement For Work Within Scope$0
-
September 19, 2025Mod P00008 · Supplemental Agreement For Work Within ScopePRODUCT DELETION$0
-
December 19, 2024Mod P00007$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Priority Healthcare Distribution Inc | Department Of Veterans Affairs | July 2, 2026 | $15.7K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79722D0202?
Contract 36F79722D0202 is a federal contract awarded to Cti Biopharma Corp. by Department Of Veterans Affairs on December 19, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36F79722D0202?
Cti Biopharma Corp. won contract 36F79722D0202 from Department Of Veterans Affairs.
How much is contract 36F79722D0202 worth?
Contract 36F79722D0202 has obligated $0 to date but carries a potential ceiling of $3.00 million if fully funded and all options are exercised.